Results 31 to 40 of about 2,834 (179)

Reversible Hemifacial Spasm after Starting Escitalopram

Case Reports in Neurology, 2020
This is a case of a patient who developed hemifacial spasm after he was started on escitalopram. His symptoms got worse after the dose was increased. The spasm resolved after the medication was stopped gradually.
Mazen Abdulrahaman Basheikh
doaj   +1 more source

Adverse Drug Reaction Study of Botulinum Toxin‐A in the Real World

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Despite the increasing use of botulinum toxin type A (BoNT‐A) in aesthetic and therapeutic applications, its real‐world adverse drug reaction (ADR) profile remains incompletely characterized. Current evidence relies largely on small‐scale clinical observations rather than large, systematic analyses.
Jiaxu Gu, Yue Sun, Kexin Chen, Jieyi Wang, Bingcheng Lu, Hongqiang Xie, Xiaoming Liu, Cong Huang, Xingling Jian, Bo Yu   +9 more
wiley   +1 more source

Botulinum toxin type A efficient treatment in patients with hemifacial spasm, Guantanamo 2018-2019

Revista Información Científica, 2020
Introduction: no research records were found addressing the results of the application of botulinum toxin type A in patients with hemifacial spasm in Guantanamo province.
Talía Marzo-Ramírez, Tamara Mecías-Díaz   +1 more
doaj  

Transposition of posterior inferior cerebellar artery could have caused ischemic complication in microvascular decompression for hemifacial spasm

Interdisciplinary Neurosurgery, 2019
Ischemic complications are generally rare complications in microvascular decompression surgery for hemifacial spasm. We report a case of posterior inferior cerebellar artery (PICA) infarction post-microvascular decompression. A 68-year old woman with a 2-
Naohide Fujita, Satoshi Adachi, Mario Suzuki, Yuzaburo Shimizu, Osamu Akiyama, Akihide Kondo   +5 more
doaj   +1 more source

Flanker Task Performance in Isolated Dystonia (Blepharospasm): A Focus on Sequential Effects

Brain Sciences, 2020
Isolated dystonia manifests with involuntary muscle hyperactivity, but the extent of cognitive impairment remains controversial. We examined the executive functions in blepharospasm while accounting for motor symptom-related distractions as a factor ...
Max Pekrul, Caroline Seer, Florian Lange, Dirk Dressler, Bruno Kopp   +4 more
doaj   +1 more source

A 25‐Year Bibliometric and Scientometric Analysis of Facial Paralysis Rehabilitation: Knowledge Structure, Influential Works, and Emerging Research Frontiers (2000–2025)

Microsurgery, Volume 46, Issue 4, May 2026.
ABSTRACT Background Facial paralysis rehabilitation has progressed substantially over the past two decades, yet the scientific landscape of this field remains highly fragmented across surgical, neurological, and rehabilitation disciplines. Despite growing clinical and technological advances—including neuromuscular retraining, chemodenervation ...
Mert Doğan, Fatma Ayvat
wiley   +1 more source

Health-related quality of life outcomes from botulinum toxin treatment in hemifacial spasm

Therapeutic Advances in Neurological Disorders, 2017
Background: Although botulinum neurotoxin (BoNT) injections may alleviate involuntary muscle contractions in hemifacial spasm substantially, it is less clear whether the motor effect would translate into improvements of health-related quality of life (HR-
Daniel Weiss, Justine Sturm, Leonhard Hieber, Axel Börtlein, Ingo Mayr, Matthias Appy, Benedicta Kühnler, Joachim Buchthal, Christian Dippon, Guy Arnold, Tobias Wächter   +10 more
doaj   +1 more source

Yield of Whole Genome Sequencing for Pathogenic Single Nucleotide Variants in Congenital Heart Disease: A Systematic Review and Meta‐Analysis

Prenatal Diagnosis, Volume 46, Issue 5-6, Page 780-818, May 2026.
ABSTRACT Objective This systematic review and meta‐analysis aimed to assess the diagnostic yield of pathogenic or likely pathogenic (P/LP) single nucleotide variants (SNVs) using whole genome sequencing (WGS) in congenital heart disease (CHD). Methods A systematic search of three databases (2000–2024) was conducted, and two reviewers independently ...
Hiba J. Mustafa, Parisa Najjariasl, Faezeh Aghajani, Enaja V. Sambatur, Andrew Rodenbarger, Stephanie Guseh, Amy E. Roberts, Alireza A. Shamshirsaz   +7 more
wiley   +1 more source

Reviving Hope: Overcoming Deep Brain Stimulation Failure With Partial Cranial Nerve Radiofrequency Ablation in Primary Meige Syndrome

Brain and Behavior, Volume 16, Issue 4, April 2026.
Partial cranial nerve radiofrequency ablation (RFA) represents a feasible and potentially effective salvage therapy for Primary Meige Syndrome following deep brain stimulation (DBS) failure. Targeting peripheral pathways may facilitate rapid symptom remission with manageable sequelae, offering a practical alternative when central neuromodulation proves
Xue Li, Min Yan, Bing Huang, Lina Yu, Huabo Liu, Hao Huang, Ming Yao   +6 more
wiley   +1 more source

Is Current Evidence Sufficient to Establish the Efficacy of Botulinum Toxin A in Treating Persistent Dry Eye Disease? A Systematic Review and Meta‐Analysis of Interventional Studies With a Critical Review Using GRADE Tool

Health Science Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background and Aims Standard management of dry eye disease (DED) relies on artificial tears, anti‐inflammatory therapy, and punctal occlusion in selected cases. However, some patients continue to report persistent symptoms. The present article reviewed the efficacy of Botulinum Toxin A (BTX‐A) for DED that remained symptomatic after these ...
Mirsaeed Abdollahi, Farbod Semnani, Hadi Vahedi, Navid Sobhi, Mahdi Mohammadkhani, Amin Nabavi, Ali Jafarizadeh   +6 more
wiley   +1 more source